Stay updated on Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial page.

Latest updates to the Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check49 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check71 days agoChange DetectedThe website has updated the intervention type to 'Verified 2020-06 by CVI Pharmaceuticals' and noted a status change to 'Recruiting' in the latest revision v2.14.0, while the previous intervention type and revision v2.13.3 have been removed.SummaryDifference3%
- Check100 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of CVI-LM001 in Hypercholesterolemia Clinical Trial page.